Adenocarcinoma of Lung Stage IV Terminated Phase 2 Trials for Poziotinib (DB12114)

Also known as: Adenocarcinoma Lung Stage IV / Lung adenocarcinoma stage IV / Stage IV Lung Adenocarcinoma / Lung adenocarcinoma metastatic / Adenocarcinoma of lung, stage IV

IndicationStatusPhase
DBCOND0062752 (Adenocarcinoma of Lung Stage IV)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01819428NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung AdenocarcinomaTreatment